 VANCOUVER, British Columbia, Nov. 10, 2020 GLOBE NEWSWIRE -- RepliCel Life Sciences Inc. OTC PK : REPCF TSXV: RP FRA:P6P2 RepliCel or the Company, a company developing next-generation technologies in aesthetics and orthopedics, announced today its intent to enter into a strategic partnership with MainPointe Pharmaceuticals MainPointe headquartered in Louisville, Kentucky. 